Ovarian Cancer Research Alliance’s Vice President of Policy, Chad Ramsey, spoke with Ellen Bryan of WUSA-TV’s Great Day Washington, and shared important new findings from a paper co-authored by OCRA and Komodo Health.
The analysis reveals that nearly half of women diagnosed with ovarian cancer don’t receive essential genetic testing, despite its impact on treatment and family risk.
Watch the segment, “Advocating for more ovarian cancer research.”
OCRA’s Spring Advocacy Day
OCRA’s Advocate Leaders and policy team met with members of Congress during OCRA’s Spring Advocacy Day to urge them to restore cancer research funding and pass critical legislation.
Nearly 120 advocates from 35 states & Washington, DC, participated, holding 135+ meetings with Congressional offices in an effort to restore funding to the Ovarian Cancer Research Program, renew commitment to gynecologic cancer research and education funding, and pass legislation to allow Medicare to cover multi-cancer early detection tests.
Free Onilne Seminar: Wednesday, April 9
“Endometrial Cancer: Understanding Biomarker Testing & Its Value in the Changing Treatment Landscape” takes place today, April 9th from 1 – 2:30 PM ET.
Dr. Ramez Eskander and Dr. Ann Klopp will answer questions during a live Q&A. Register here.
This event is made possible with support from AstraZeneca and Merck.
OCRA Rivkin Family SummeRun
Seattle’s iconic 5K run/walk for ovarian cancer awareness, now hosted by OCRA, returns on July 13th to Seward Park in Seattle. OCRA is proud to carry forward Rivkin Center’s legacy of turning hope into action for everyone impacted by ovarian cancer. Funds raised will support Rivkin Pilot Grants.
New Support Sessions & Roundtables
Staying Connected:
Cancer en Espanol
17 abril, 12pm ET
Register here.
Free Online Roundtable:
Coping With the Unknown
April 30th at 1pm ET
Register here.
Free Online Roundtable:
Advocating for Your Community and Healthcare Needs
May 28th at 1pm ET
Register here.
New! Staying Current:
Interactive sessions focused on treatment standards of care and clinical trials for those newly diagnosed and recurrent ovarian cancer. Facilitated by Anne Mette Buhl, PhD, Senior Director of Treatment Access and Scientific Education.
Register here.
Ways to Give
From estate planning and workplace giving, to tribute pages and fundraising events, there are so many ways to support OCRA in funding vital research, advocating for our community, and supporting those impacted by ovarian and all gynecologic cancers.
